CIC
GILD icon

Chilton Investment Company’s Gilead Sciences GILD Stock Holding History

Chilton Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
2,056
-54
-3% -$7.12K 0.01% 276
2026
Q1 		$294K Hold
2,110
– – 0.01% 251
2025
Q4 		$259K Buy
+2,110
New +$256K 0.01% 254

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chilton Investment Company's GILD Position: Q2 2026 in Review

Chilton Investment Company reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $7.12K and leaving 2,056 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #276.

Chilton Investment Company first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $294K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chilton Investment Company held 2,056 shares of Gilead Sciences worth $260K as of Q2 2026.
  • Chilton Investment Company sold 54 Gilead Sciences shares in Q2 2026, an estimated $7.12K.
  • Gilead Sciences made up 0.01% of Chilton Investment Company's portfolio in Q2 2026, its #276 holding.
  • Chilton Investment Company first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Chilton Investment Company's Gilead Sciences position peaked at $294K in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chilton Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.